Research and Development Activities
First written in FY2016-Q3. 24 of 33 entries say "Restated". Latest entry: FY2026-H1.
96 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「The Group's total R&D expenditure during the interim consolidated accounting period was ¥41 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D expenditure for the interim period was ¥41 million, with no material changes in the status of R&D activities. - FY2025Expansion of R&D targetsAnnual report
「The Company is developing an internal cylindrical grinding machine capable of simultaneously machining the inner and outer diameters of a workpiece, based on an internal cylindrical grinding machine and using knowledge gained from centerless grinding machines. …It is working to enter the fastener industry, which supplies parts for aircraft, as a field outside the automotive industry. …It is working to establish grinding conditions and optimize machine structures to reduce dimensional variation and improve roundness in ultra-fine workpieces.」
In addition to its existing spindles, AI and medical devices, the Company identifies simultaneous inner- and outer-diameter machining, aircraft fasteners and ultra-fine semiconductor-related components as R&D and application targets. - FY2024AdvancedAnnual report
「R&D expenditure for the consolidated fiscal year was ¥121 million. …Sales of the μ-ForceOne for internal cylindrical grinding machines have begun.」
The Company recorded R&D expenditure of ¥121 million and stated that it had begun selling the μ-ForceOne dynamometer for internal cylindrical grinding machines in its AI and sensing business. It has continued developing AI technology after the end of its joint development project with NEDO. - FY2024-Q2RestatedAnnual report
「The amount spent on research and development by the Group as a whole during the six-month cumulative period of the second quarter was ¥63 million. There were no material changes in the status of the Group's research and development activities during the six-month cumulative period of the second quarter.」
R&D expenditure for the six-month period was ¥63 million, with no material changes in the status of R&D activities. - FY2024-Q1RestatedAnnual report
「The Group's total R&D expenditure during the three-month period ended 30 June was ¥36 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D expenditure for the three-month period was ¥36 million, with no material changes in the status of R&D activities. - FY2023AdvancedAnnual report
「R&D expenditure for the consolidated fiscal year was ¥157 million. The Company now sells 150,000 rpm and 180,000 rpm spindles, as well as 90,000 rpm, 120,000 rpm and 150,000 rpm through-spindle coolant spindles.」
R&D expenditure was ¥157 million, and the Company has expanded its product lineup of in-house high-frequency spindles. It also stated that it had commercialized nose and ear models for medical surgical training. - FY2023-Q3RestatedAnnual report
「The amount spent on research and development by the Group as a whole during the nine-month cumulative period of the third quarter was ¥117 million. There were no material changes in the status of the Group's research and development activities during the nine-month cumulative period of the third quarter.」
The Company recorded R&D expenditure of ¥117 million, with no material changes in the status of R&D activities. - FY2023-Q2RestatedAnnual report
「The amount spent on research and development activities across the Group during the six months ended the second quarter was ¥79 million. There were no material changes in the status of the Group’s research and development activities during the six months ended the second quarter.」
Records R&D expenses of ¥79 million and states that there have been no material changes in the status of R&D activities. - FY2023-Q1RestatedAnnual report
「The Group's total R&D expenditure during the three-month period ended 30 June was ¥33 million. There were no material changes in the status of the Group's R&D activities during the period.」
The Company recorded R&D expenditure of ¥33 million, with no material changes in the status of R&D activities. - FY2022AdvancedAnnual report
「R&D expenditure for the consolidated fiscal year was ¥150 million. In addition, the Company commercialized a medical surgical training model, featuring a nose, to promote sales of these surgical instruments.」
R&D expenditure was ¥150 million, and the Company stated that it had commercialized a model for promoting sales of surgical instruments in its medical device business, indicating progress in commercializing its R&D成果. - FY2022-Q3RestatedAnnual report
「The group's R&D expenses for the cumulative third quarter were ¥108 million. There was no material change in the status of the group's R&D activities during the cumulative third quarter.」
R&D expenditure for the nine-month period was ¥108 million, with no material changes in the status of R&D activities. - FY2022-Q2RestatedAnnual report
「The group's research and development expenditure for the first half of the consolidated cumulative period was ¥72 million. There were no material changes in the status of the group's research and development activities during the first half of the consolidated cumulative period.」
R&D expenditure for the six-month period was ¥72 million, with no material changes in the status of R&D activities. - FY2022-Q1RestatedAnnual report
「The amount spent on research and development by the Group as a whole during the three-month cumulative period of the first quarter was ¥31 million. There were no material changes in the status of the Group's research and development activities during the three-month cumulative period of the first quarter.」
R&D expenditure for the three-month period was ¥31 million, with no material changes in the status of R&D activities. - FY2021AdvancedAnnual report
「R&D expenditure for the consolidated fiscal year was ¥114 million.」
The Company reported R&D expenditure of ¥114 million and described the commercialization of R&D成果, including a dynamometer for sensing grinding resistance, AI-equipped grinding machines, and obtaining regulatory approvals for medical devices and selling products under its own brand. - FY2021-Q3RestatedAnnual report
「The Group's total R&D expenditure during the nine-month period ended 31 December was ¥83 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D expenditure for the nine-month period was ¥83 million, with no material changes in the status of R&D activities. - FY2021-Q2RestatedAnnual report
「The Group’s total R&D expenditure for the first six months of the current consolidated cumulative period was ¥50 million. There were no material changes in the status of the Group’s R&D activities during the first six months of the current consolidated cumulative period.」
R&D expenditure for the six-month period was ¥50 million, with no material changes in the status of R&D activities. - FY2021-Q1RestatedAnnual report
「The amount spent on research and development by the Group as a whole during the three-month cumulative period of the first quarter was ¥23 million. There were no material changes in the status of the Group's research and development activities during the three-month cumulative period of the first quarter.」
R&D expenditure for the three-month period was ¥23 million, with no material changes in the status of R&D activities. - FY2020AdvancedAnnual report
「R&D expenditure for the consolidated fiscal year was ¥162 million. In recent years, demand has increased for screws used in drive actuators for motors as automobiles have become increasingly electrified, attracting interest in the Company's MPC-500ⅡTH-RDT-CNC model centerless grinding machine for mass-production thread-groove grinding, which the Company developed.」
The Company recorded R&D expenditure of ¥162 million and described the development and market interest in a machine for mass-production thread-groove grinding, as well as receiving the Machinery Promotion Award and the Monozukuri Nippon Grand Award, indicating specific progress in its R&D成果. - FY2020-Q3RestatedAnnual report
「The Group's total R&D expenditure during the nine-month period ended 31 December was ¥120 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D expenses of ¥120 million were recorded, and it was stated that there had been no significant changes in R&D activities. - FY2020-Q2RestatedAnnual report
「The Group's total R&D expenditure during the six-month period ended 30 September was ¥83 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D expenditure was ¥83 million, with no material changes in the status of R&D activities. - FY2020-Q1RestatedAnnual report
「The group’s research and development expenditure for the cumulative first quarter period was ¥22 million. There were no material changes in the status of the group’s research and development activities during the cumulative first quarter period.」
R&D expenditure for the three-month period was ¥22 million, with no material changes in the status of R&D activities. - FY2019-Q3RestatedAnnual report
「The Group's total R&D expenditure during the nine-month period ended 31 December was ¥112 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D expenditure for the nine-month period was ¥112 million, with no material changes in the status of R&D activities. - FY2019-Q2RestatedAnnual report
「The Group's total R&D expenditure during the six-month period ended 30 September was ¥82 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D expenditure for the six-month period was ¥82 million, with no material changes in R&D activities. - FY2019-Q1RestatedAnnual report
「The Group's total R&D expenditure during the three-month period ended 30 June was ¥28 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D expenditure was ¥28 million, with no material changes in the status of R&D activities. - FY2018AdvancedAnnual report
「R&D expenditure for the consolidated fiscal year was ¥100 million. In October 2014, the Company developed and began selling its in-house MIS-150P/0.5 spindle for internal cylindrical grinding machines. It subsequently developed and began selling a 90,000 rpm through-spindle coolant spindle, an 180,000 rpm spindle and a 150,000 rpm through-spindle coolant spindle as additions to its product lineup.」
R&D expenditure was ¥100 million, and the Company expanded its product lineup by developing and beginning sales of 90,000 rpm through-spindle coolant, 180,000 rpm and 150,000 rpm spindles. - FY2018-Q3RestatedAnnual report
「The Group's total R&D expenditure during the nine-month period ended 31 December was ¥87 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D expenditure for the nine-month period was ¥87 million, with no material changes in the status of R&D activities. - FY2018-Q2RestatedAnnual report
「The Group's total R&D expenditure during the six-month period ended 30 September was ¥42 million. There were no material changes in the status of the Group's R&D activities during the period.」
R&D expenditure for the six-month period was ¥42 million, with no material changes in the status of R&D activities. - FY2018-Q1RestatedAnnual report
「The group’s research and development expenditure for the cumulative first quarter period was ¥18 million. There were no material changes in the status of the group’s research and development activities during the cumulative first quarter period.」
The disclosure reports research and development expenditure of ¥18 million for the first-quarter period and states that there have been no material changes in research and development activities. - FY2017RestatedAnnual report
「Research and development expenditure for the current consolidated fiscal year was ¥139 million. In October 2014, the Company developed and began selling the MIS-150P/0.5 in-house spindle for internal grinding machines. Because this spindle is a key unit governing the precision of internal grinding machines, the Company pursued in-house production, targeting equipment used to manufacture fuel supply systems for automotive engines. During the current consolidated fiscal year, the Company has been working diligently to expand its lineup of in-house spindles.」
The disclosure reports research and development expenditure of ¥139 million and states that the Group continues to expand its lineup of in-house spindles. No new, specifically identified completed milestone is disclosed relative to the research and development policy presented in the previous fiscal year. - FY2017-Q2RestatedAnnual report
「The Group’s research and development expenditure for the six-month period of the current consolidated fiscal year was ¥84 million. There were no material changes in the Group’s research and development activities during the six-month period of the current consolidated fiscal year.」
The disclosure reports research and development expenditure of ¥84 million for the six-month period and states that there have been no material changes in research and development activities. - FY2017-Q1RestatedAnnual report
「The amount spent on research and development activities across the Group during the first quarter of the current consolidated cumulative period was ¥36 million. There were no material changes in the status of the Group's research and development activities during the first quarter of the current consolidated cumulative period.」
The disclosure reports first-quarter research and development expenditure of ¥36 million and states that there have been no material changes in research and development activities. - FY2016AdvancedAnnual report
「Research and development expenditure for the current consolidated fiscal year was ¥134 million. In October 2014, the Company developed and began selling the MIS-150P/0.5 in-house spindle for internal grinding machines. During the current consolidated fiscal year, the Company has been working diligently to expand its lineup of in-house spindles. It is also focusing on developing operating peripheral equipment, including software, for both centerless and internal grinding machines, and will continue working to provide easy-to-use products.」
The disclosure reports full-year research and development expenditure of ¥134 million and describes specific progress in expanding the lineup of in-house spindles and developing peripheral equipment and software. - FY2016-Q3First statedAnnual report
「The Group’s research and development expenditure for the nine-month period of the current consolidated fiscal year was ¥97 million.」
The disclosure reports research and development expenditure of ¥97 million for the nine-month period of the current consolidated fiscal year.